X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (98201) 98201
Book Review (19347) 19347
Publication (11386) 11386
Book Chapter (771) 771
Conference Proceeding (293) 293
Book / eBook (284) 284
Dissertation (76) 76
Reference (28) 28
Magazine Article (18) 18
Data Set (12) 12
Paper (5) 5
Presentation (5) 5
Web Resource (5) 5
Newspaper Article (4) 4
Government Document (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (92114) 92114
humans (69026) 69026
animals (48369) 48369
female (28580) 28580
mice (21922) 21922
oncology (21804) 21804
cell biology (19013) 19013
male (18167) 18167
signal transduction (17551) 17551
biochemistry & molecular biology (16875) 16875
expression (15963) 15963
cancer (15550) 15550
receptor, epidermal growth factor - metabolism (15342) 15342
cell line, tumor (13388) 13388
phosphorylation (12518) 12518
proteins (11515) 11515
research (11072) 11072
middle aged (11037) 11037
cells, cultured (10233) 10233
gene expression (10209) 10209
rats (9762) 9762
epidermal growth factor (9638) 9638
adult (9378) 9378
breast cancer (9174) 9174
growth-factor receptor (9132) 9132
immunohistochemistry (8726) 8726
aged (8713) 8713
receptor (8695) 8695
activation (8693) 8693
analysis (8684) 8684
apoptosis (8332) 8332
cell line (8320) 8320
article (8164) 8164
cells (7997) 7997
physiological aspects (7330) 7330
breast neoplasms - metabolism (7199) 7199
tumors (7156) 7156
receptors (6947) 6947
research article (6848) 6848
mutation (6846) 6846
endocrinology & metabolism (6540) 6540
kinases (6514) 6514
cell proliferation (6504) 6504
multidisciplinary sciences (6470) 6470
receptor, erbb-2 - metabolism (6420) 6420
genetic aspects (6405) 6405
signal transduction - drug effects (6366) 6366
gene-expression (6161) 6161
breast neoplasms - pathology (6139) 6139
receptor, epidermal growth factor - genetics (6051) 6051
prognosis (6023) 6023
medicine (5930) 5930
pharmacology & pharmacy (5889) 5889
health aspects (5874) 5874
care and treatment (5264) 5264
metastasis (5226) 5226
ligands (5124) 5124
tumor cells, cultured (5051) 5051
growth (4987) 4987
cell proliferation - drug effects (4955) 4955
molecular sequence data (4858) 4858
signal transduction - physiology (4851) 4851
gene expression regulation, neoplastic (4782) 4782
biology (4780) 4780
egfr (4763) 4763
physiology (4686) 4686
in-vitro (4680) 4680
epidermal-growth-factor (4662) 4662
proliferation (4662) 4662
rodents (4638) 4638
protein binding (4621) 4621
chemotherapy (4610) 4610
blotting, western (4593) 4593
epidermal growth factor - pharmacology (4555) 4555
epidermal growth factor - metabolism (4548) 4548
antineoplastic agents - pharmacology (4532) 4532
breast-cancer (4513) 4513
medicine & public health (4490) 4490
protein (4463) 4463
abridged index medicus (4437) 4437
pathology (4426) 4426
neurosciences (4425) 4425
rna, messenger - metabolism (4374) 4374
immunology (4371) 4371
receptor, epidermal growth factor - antagonists & inhibitors (4335) 4335
science (4230) 4230
in-vivo (4177) 4177
amino acid sequence (4117) 4117
development and progression (4056) 4056
medicine, research & experimental (4027) 4027
genes (4008) 4008
antineoplastic agents - therapeutic use (3974) 3974
differentiation (3973) 3973
transfection (3936) 3936
inflammation (3929) 3929
aged, 80 and over (3897) 3897
models, biological (3821) 3821
breast neoplasms - drug therapy (3720) 3720
carcinoma (3700) 3700
biochemistry (3683) 3683
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (199) 199
UofT at Mississauga - Stacks (14) 14
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
UTL at Downsview - May be requested (11) 11
UofT at Scarborough - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (97704) 97704
Chinese (492) 492
Japanese (201) 201
Russian (120) 120
French (99) 99
German (47) 47
Spanish (40) 40
Hungarian (17) 17
Korean (16) 16
Polish (13) 13
Bulgarian (10) 10
Italian (9) 9
Czech (7) 7
Danish (5) 5
Romanian (3) 3
Turkish (3) 3
Ukrainian (3) 3
Arabic (2) 2
Dutch (2) 2
Hebrew (2) 2
Portuguese (2) 2
Serbian (2) 2
Croatian (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncogene, ISSN 0950-9232, 12/2010, Volume 29, Issue 49, pp. 6485 - 6498
Journal Article
2008, Cancer drug discovery and development, ISBN 9781597453561, xi, 393
The epidermal growth factor (EGF) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor... 
drug therapy | Signal Transduction | drug effects | metabolism | Neoplasms | antagonists & inhibitors | Receptor, Epidermal Growth Factor | Clinical & internal medicine | Cancer | Chemotherapy | Treatment | Medicine & Public Health | Cancer Research | Oncology
Book
Nature Cell Biology, ISSN 1465-7392, 03/2010, Volume 12, Issue 3, pp. 267 - 272
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3239 - 3247
Journal Article
Cancer, ISSN 0008-543X, 10/2014, Volume 120, Issue 19, pp. 2980 - 2985
Simultaneous targeting of the IGF‐1R and EGFR signaling pathways for more effective downstream inhibition of proliferation and survival did not improve... 
pancreatic cancer | erlotinib signaling | randomized phase II | IGF‐1R | cixutumumab | EGFR | targeted treatment | Erlotinib signaling | Targeted treatment | Randomized phase II | Pancreatic cancer | Cixutumumab | IGF-1R | CARCINOMA-CELLS | DUCTAL ADENOCARCINOMA | MONOCLONAL-ANTIBODY | SINGLE-AGENT CETUXIMAB | BREAST-CANCER | INHIBITION | K-RAS | ONCOLOGY | THERAPEUTIC TARGET | C-MET | RESISTANCE | Erlotinib Hydrochloride | Pancreatic Neoplasms - metabolism | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptor, Epidermal Growth Factor - drug effects | Male | Insulin-Like Growth Factor I - drug effects | Pancreatic Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - metabolism | Adenocarcinoma - metabolism | Adult | Deoxycytidine - adverse effects | Female | Quinazolines - administration & dosage | Drug Administration Schedule | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Kaplan-Meier Estimate | Treatment Outcome | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Signal Transduction - drug effects | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Insulin-Like Growth Factor I - metabolism | Index Medicus | Abridged Index Medicus
Journal Article
Cancer Science, ISSN 1347-9032, 08/2016, Volume 107, Issue 8, pp. 1134 - 1140
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 506, Issue 7487, pp. 230 - 234
There are no clinically relevant treatments available that improve function in the growing population of very preterm infants (less than 32 weeks' gestation)... 
MULTIPLE-SCLEROSIS | LOW-BIRTH-WEIGHT | OLIGODENDROCYTE PROGENITORS | MULTIDISCIPLINARY SCIENCES | HYPOXIC INJURY | CENTRAL-NERVOUS-SYSTEM | MOUSE CORPUS-CALLOSUM | PRETERM INFANTS | RAT-BRAIN | WHITE-MATTER ABNORMALITIES | FACTOR RECEPTOR | Epidermal Growth Factor - administration & dosage | Oligodendroglia - metabolism | Receptor, Epidermal Growth Factor - genetics | Demyelinating Diseases - congenital | Brain Injuries - drug therapy | Humans | Brain Injuries - congenital | Male | Stem Cells - cytology | Demyelinating Diseases - metabolism | Epidermal Growth Factor - therapeutic use | Molecular Targeted Therapy | Stem Cells - metabolism | Cell Lineage - drug effects | Hypoxia - metabolism | Receptor, Epidermal Growth Factor - metabolism | Oligodendroglia - drug effects | Time Factors | Oligodendroglia - cytology | Demyelinating Diseases - pathology | Disease Models, Animal | Animals, Newborn | Cell Survival - drug effects | Demyelinating Diseases - prevention & control | Administration, Intranasal | Infant, Premature, Diseases - drug therapy | Cell Division - drug effects | Brain Injuries - prevention & control | Oligodendroglia - pathology | Hypoxia - genetics | Regeneration - drug effects | Animals | Signal Transduction - drug effects | Cell Differentiation - drug effects | Hypoxia - pathology | Stem Cells - drug effects | Hypoxia - physiopathology | Infant, Premature, Diseases - metabolism | Mice | Epidermal Growth Factor - pharmacology | Brain Injuries - pathology | Infant, Premature, Diseases - pathology | Brain | Medical research | Care and treatment | Infants (Premature) | Risk factors | Complications and side effects | Epidermal growth factor | Physiological aspects | Medicine, Experimental | Hypoxia | Diagnosis | Health aspects | Injuries | Attention deficit disorder | Brain damage | Rodents | Apoptosis | Index Medicus
Journal Article
Journal Article